Spinraza (Biogen)


Welcome to the PulseAid listing for the Spinraza drug offered from Biogen. This Survival Motor Neuron-2-directed RNA Interaction [EPC],Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient],Increased Protein Synthesis [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Biogen
NON-PROPRIETARY NAME: Nusinersen
SUBSTANCE NAME: NUSINERSEN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Survival Motor Neuron-2-directed RNA Interaction [EPC],Antisense Oligonucleotide [EPC],Oligonucleotides, Antisense [Chemical/Ingredient],Increased Protein Synthesis [PE]
ROUTE: INTRATHECAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-12-23
END MARKETING DATE: 0000-00-00


Spinraza HUMAN PRESCRIPTION DRUG Details:

Item DescriptionSpinraza from Biogen
LABELER NAME: Biogen
DEA SCHEDULE:
ACTIVE STRENGTH: 2.4(mg/mL)
START MARKETING DATE: 2016-12-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 64406-058_1514085a-8cbb-4690-b477-fdf70f34d726
PRODUCT NDC: 64406-058
APPLICATION NUMBER: NDA209531

Other NUSINERSEN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
BiogenSpinraza